A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer
Conditions:   Small Cell Lung Carcinoma (SCLC);   Neuroendocrine Neoplasms Interventions:   Drug: BI 764532;   Drug: [89Zr]Zr-BI 764532 Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
Condition:   Small-cell Lung Cancer Intervention:   Drug: Serplulimab Sponsors:   Guangdong Association of Clinical Trials;   Guangdong Provincial People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2023 Category: Research Source Type: clinical trials